VACCINE FOR PROTECTING AGAINST NEWCASTLE BIRD DISEASE

veterinary medicine. SUBSTANCE: vaccine contains extraembryonic liquid of hen embryo containing La Sota vaccine strain culture. The vaccine also has saccharose, peptone, casein, resin, aerosil and additional casein taken in known per cent proportions. The vaccine is produced by applying contact dehy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SMOLENSKIJ V.I, RUDENKO T.V, MAKHLAJ A.A, KRAMSKOJ N.V, FILONENKO V.I, GRIGORENKO A.I, TOKARIK EH.F, FISININ V.I, GOREVA I.P, KOLOSKOV A.V
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	veterinary medicine. SUBSTANCE: vaccine contains extraembryonic liquid of hen embryo containing La Sota vaccine strain culture. The vaccine also has saccharose, peptone, casein, resin, aerosil and additional casein taken in known per cent proportions. The vaccine is produced by applying contact dehydration method. The vaccine is administered per os to 20-270 days old birds when given with food at a dose of 0.25 g/bird. EFFECT: enhanced effectiveness in protection against the disease; no adverse side effects. 7 tbl